Antibody-drug conjugate (ADC) is an effective combination of chemotherapy and immunotherapy. The concept was first proposed more than 100 years ago by German scientist Paul Ehrlich. He likens ADCs to "wonder drugs" because they can clearly identify targets (cancer cells) without harming the ...
